Kangstem Biotech
A South Korean biotech company developing stem cell therapies and organoid-based technologies.
Last updated September 1, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Kangstem Biotech is a South Korean biotech company focused on developing stem cell therapies and organoid-based technologies. The company was established on October 29, 2010, and is headquartered in Seoul. It is listed on KOSDAQ. Its main pipeline includes treatments for osteoarthritis, atopic dermatitis, and rheumatoid arthritis, as well as skin organoid technology.
History
Kangstem Biotech was established on October 29, 2010. In December 2015, it was listed on KOSDAQ. The company has developed various stem cell therapies and organoid technologies, including treatments for osteoarthritis, atopic dermatitis, and rheumatoid arthritis.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/kangstem-biotech-co-ltd-south-korea · Editorial policy · How profiles are compiled